Eikon cuts staff 'to become more efficient,' letter from CEO Perlmutter reveals

Eikon Therapeutics, a biotech that snatched several big-name executives from Merck & Co. and raked in some of the largest financing rounds in recent memory, has cut staff in an effort to “become more efficient.”